Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jared Gollob | Chief Medical Officer | 2025-10-15 | 14,896 | $62.72 | $934.32kSell |
Jared Gollob | Chief Medical Officer | 2025-10-15 | 8,963 | $61.49 | $551.16kSell |
Jared Gollob | Chief Medical Officer | 2025-10-15 | 29,264 | $60.37 | $1.77MSell |
Jared Gollob | Chief Medical Officer | 2025-10-15 | 28,999 | $1.31 | $37.99kBuy |
Jared Gollob | Chief Medical Officer | 2025-10-15 | 22,210 | $2.08 | $46.20kBuy |
Jared Gollob | Chief Medical Officer | 2025-10-15 | 6,453 | $63.09 | $407.10kSell |
Jared Gollob | Chief Medical Officer | 2025-10-13 | 673 | $2.08 | $1.40kBuy |
Jeffrey W. Albers | Director | 2025-10-13 | 5,000 | $10.34 | $51.70kBuy |
Jeffrey W. Albers | Director | 2025-10-13 | 5,000 | $59.19 | $295.95kSell |
Jared Gollob | Chief Medical Officer | 2025-10-13 | 3,114 | $60.00 | $186.84kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Price T Rowe Associates Inc | 9.59% | 6,859,202 | $414.71M | Institution |
Baker Bros Advisors LP | 9.30% | 6,651,429 | $402.15M | Institution |
Avoro Capital Advisors LLC | 9.17% | 6,555,555 | $396.35M | Institution |
Baker Bros Advisors LP | 8.56% | 6,117,295 | $369.85M | Insider |
Atlas Venture Associates X LP | 8.06% | 5,763,012 | $348.43M | Insider |
Vanguard Group Inc | 7.86% | 5,619,848 | $339.78M | Institution |
Atlas Venture Fund X LP | 7.70% | 5,504,905 | $332.83M | Insider |
Bvf Inc | 7.70% | 5,502,710 | $332.69M | Institution |
Fmr LLC | 7.60% | 5,431,994 | $328.42M | Institution |
Wellington Management Group LLP | 7.51% | 5,372,061 | $324.79M | Institution |